The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health

• Egile Nagusiak: Rosângela Caetano (Egilea), Paulo Henrique Almeida Rodrigues (Egilea), Marilena C Villela Corrêa (Egilea), Pedro Villardi (Egilea), Claudia Garcia Serpa Osorio- (Egilea)
• Formatua: Liburua
• Argitaratua: Universidade de São Paulo, 2020-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

ABSTRACT OBJECTIVES This study examined the purchases of eculizumab, a high-cost monoclonal antibody used in the treatment of rare diseases by Brazilian federal agencies, in terms of purchased quantities, expenditures, and prices. METHODS Eculizumab purchases made between March 2007 and December 201...